eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 19/09/2011
PIL Bondronat 6mg/6ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 30/08/2011 and displayed until 19/09/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/07/2011 and displayed until 30/08/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/05/2011 and displayed until 08/07/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 04/02/2010 and displayed until 05/05/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 24/06/2009 and displayed until 04/02/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 26/03/2007 and displayed until 24/06/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 25/07/2006 and displayed until 26/03/2007
Reasons for adding or updating:
  • Change to storage instructions
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 23/08/2004 and displayed until 25/07/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 24/12/2003 and displayed until 23/08/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  ibandronic acid, monosodium salt, monohydrate